ArticleACS medicinal chemistry letters2024

How Shilajit-Based Nanocarriers Alter Classical Doxorubicin Delivery to Breast Cancer Cells (MCF-7 and ZR-75-1).

Zahra Asadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.